CHANGES IN SERUM PROTEINS AND CEREBROSPINAL FLUID PROTEINS DURING PHARMACOTHERAPY OF PSYCHOSES.
D000437:Alcoholism; D001714:Bipolar Disorder; D001798:Blood Proteins; D002556:Cerebrospinal Fluid Proteins; D002746:Chlorpromazine; D004358:Drug Therapy; D006220:Haloperidol; D006801:Humans; D007122:Immunoelectrophoresis; D001523:Mental Disorders; D009069:Movement Disorders; D010291:Paresis; D010546:Perphenazine; D011618:Psychotic Disorders; D012559:Schizophrenia; D013881:Thioridazine; D014116:Toxicology
D001798:Blood Proteins; D002556:Cerebrospinal Fluid Proteins; D010546:Perphenazine; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine
ALCOHOLISM; BLOOD PROTEINS; CEREBROSPINAL FLUID PROTEINS; CHLORPROMAZINE; DRUG THERAPY; HALOPERIDOL; IMMUNOELECTROPHORESIS; MOVEMENT DISORDERS; PARESIS; PERPHENAZINE; PSYCHOSES; PSYCHOSES, MANIC-DEPRESSIVE; SCHIZOPHRENIA; THIORIDAZINE; TOXICOLOGIC REPORT